For esophageal adenocarcinoma with extensive associated Barrett's, would you extend your CTV coverage beyond the usual expansions to cover the areas of known Barrett's?

Topics: Radiation Oncology • Gastrointestinal Cancers • Esophageal Cancer

Would it make a difference whether the patient was planned for chemoradiation followed by surgery or definitive nonoperative chemoradiation?

Answer from: Radiation Oncologist at Academic Institution

The standard GTV to CTV expansions may include much of the Barrett's, but I would not deliberately target the Barrett's disease, whether treating with neoadjuvant or definitive intent. Chemoradiation is not a proven therapy for Barrett's disease, but treating a larger field will expose more heart an...

Comments

Radiation Oncologist at Froedtert South
Thank you for your response. Follow-up question: ...

Radiation Oncologist at Brigham and Women's Hospital
Yes, that is what I meant when I wrote that the GT...

Related Questions